GrayMatters Health

GrayMatters HealthGrayMatters Health
GrayMatters Health

GrayMatters Health

Health tech company developing digital biomarkers for mental disorder treatment.

2018Active30
Rate

About

GrayMatters Health (GMH) is a health technology company focused on developing and marketing innovative solutions for treating mental disorders. Their approach is based on the world's first digital brain biomarkers, aiming to provide more precise and effective therapeutic interventions. The company has received recognition, including the 2023 USA Prix Galien Best Startup award, and is actively deploying its FDA-cleared Prism for PTSD.

Technology stack

detected 2026-06-30
EmailMicrosoft 365
Stack
Wix
Observability
Sentry
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does GrayMatters Health do?

GrayMatters Health (GMH) is a health technology company focused on developing and marketing innovative solutions for treating mental disorders. Their approach is based on the world's first digital brain biomarkers, aiming to provide more precise and effective therapeutic interventions. The company has received recognition, including the 2023 USA Prix Galien Best Startup award, and is actively deploying its FDA-cleared Prism for PTSD.

How much funding has GrayMatters Health raised?

GrayMatters Health has raised a total of $10M in funding. The most recent round on record is Series A.

Where is GrayMatters Health headquartered?

GrayMatters Health is headquartered in New York, United States.

When was GrayMatters Health founded?

GrayMatters Health was founded in 2018.

What industry does GrayMatters Health operate in?

GrayMatters Health operates in Healthcare, Neuromodulation, Mental Health, HealthTech, MedTech, Mental Health Tech.

How many employees does GrayMatters Health have?

GrayMatters Health has approximately 30 people on record.